Evaluating performance and quality of a fast multi‐contrast scan in routine brain MRI
Journal of Neuroimaging · 2025
DOI: 10.1111/jon.13248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroimaging, 2025. Verfasst von Eugene Milshteyn und 7 weiteren Autor:innen. Beteiligte Einrichtung: GE HealthCare, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Brain, Signal-To-Noise Ratio. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background and Purpose Neuromix is a fast, motion robust multi‐contrast sequence capable of providing all diagnostic contrasts in ∼3.5 minutes. However, more evaluation is needed across the various contrasts compared to gold standard, optimized sequences routinely used in the clinic. The goal of this study was to prospectively determine how NeuroMix performs in the clinical setting compared to routine clinical MRI.
Methods
NeuroMix and routine clinical MRI sequences were acquired on a 3 Tesla clinical scanner for 39 patients clinically indicated for brain MRI. Three radiologists were asked to assess the diagnostic confidence of NeuroMix compared to the routine MRI using a series of questions. Signal‐to‐noise and contrast‐to‐noise ratios (SNR and CNR) were assessed for NeuroMix. Fleiss’ free‐marginal multirater kappa was calculated for the qualitative assessment performed by the radiologists.
Results
Radiologists were comfortable substituting or reading some of the NeuroMix sequences in place of the corresponding conventional sequence for some contrasts, including diffusion‐weighted imaging, single‐shot T 2 , and susceptibility‐weighted imaging. The image quality, SNR, and CNR allowed the radiologists to visualize anatomy and pathology on NeuroMix images. There was no significant difference between coefficient of variation for the apparent diffusion coefficient maps ( p = .084).
Conclusions
Analysis revealed both positives and some pitfalls of NeuroMix. However, these results indicate Neuromix as having the capability to be a backup sequence in case artifacts are present in routine sequences, or potentially a replacement for some contrasts altogether.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GE HealthCare, Boston, Massachusetts, USA.
- Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
- GE HealthCare, Stockholm, Sweden.
- Karolinska Institutet, Stockholm, Sweden.
- Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Eugene Milshteyn
Zitieren
APA
Milshteyn, E., Griffin, H., Chang, Y. S., Shaikh, I., Sprenger, T., Skare, S., Maclellan, C. J., & Soman, S. (2025). Evaluating performance and quality of a fast multi‐contrast scan in routine brain MRI. Journal of Neuroimaging. https://doi.org/10.1111/jon.13248
Vancouver
Milshteyn E, Griffin H, Chang YS, Shaikh I, Sprenger T, Skare S, et al. Evaluating performance and quality of a fast multi‐contrast scan in routine brain MRI. Journal of Neuroimaging. 2025. doi:10.1111/jon.13248
BibTeX
@article{Milshteyn2025,
author = {Milshteyn, Eugene and Griffin, Harry and Chang, Yi Shuen and Shaikh, Ibraheem and Sprenger, Tim and Skare, Stefan and Maclellan, Christopher J and Soman, Salil},
title = {Evaluating performance and quality of a fast multi‐contrast scan in routine brain MRI},
journal = {Journal of Neuroimaging},
year = {2025},
doi = {10.1111/jon.13248}
}
EUVIMED